Pulmoner Sarkoidozlu Bir Hastanın F-18 FDG PET/BT Görüntülemesi
Öz
Anahtar Kelimeler
References
- Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996;26(4):308-14.
- Brudin LH, Valind SO, Rhodes CG, Pantin CF, Sweatman M, Jones T, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med. 1994;21(4):297-305.
- Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med. 1994;35(10):1647-9.
- Gotway MB, Storto ML, Golden JA, Reddy GP, Webb WR. Incidental detection of thoracic sarcoidosis on whole-body 18fluorine-2- fluoro-2-deoxy- D-glucose positron emission tomography. J Thorac Imaging. 2000;15(3):201-4.
- Braun JJ, Kessler R, Constantinesco A, Imperiale A. (18)F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging, 2008 35(8):1537–1543.
- Arfi J, Kerrou K, Traore S, Huchet V, Bolly A, Antoine M, et al. F-18 FDG PET/CT findings in pulmonary necrotizing sarcoid granulomatosis. Clin Nucl Med. 2010 Sep;35(9):697-700.
- Basu S, Saboury B, Werner T, Alavi A. Clinical Utility of FDG-PET and PET/CT in Non-malignant Thoracic Disorders. Mol Imaging Biol. 2010 Dec 16.
Details
Primary Language
Turkish
Subjects
-
Journal Section
-
Authors
Pelin Özcan Kara
Taylan Kara
Gonca Kara Gedik
Oktay Sarı
Murat İsmailoğlu
Publication Date
December 1, 2011
Submission Date
-
Acceptance Date
-
Published in Issue
Year 2011 Number: 4